First Defense® is the only USDA accredited, colostrum derived, scours preventative providing Immediate Immunity™ against E. coli, coronavirus and rotavirus (three main causes of neonatal scours). Scours is the primary cause of death in newborn calves and is a serious economic drain for bot...
Interaction between microbiota and immunity in health and disease Regulation of chromatin by histone modifications A thermosensor FUST1 primes heat-induced stress granule formation via biomolecular condensation in Arabidopsis Author Correction: A thermosensor FUST1 primes heat-induced stress granule formation...
InvivoGen provides biological tools for research in cellular and molecular biology, especially in the areas of innate immunity and mammalian cell culture.
AGO2 mediates immunotherapy failure via suppressing tumor IFN-gamma response-dependent CD8+ T cell immunity Yuzhao Wang, ... Zikun Ma22 April 2025View PDF Research articleOpen access Hi-C profiling in tissues reveals 3D chromatin-regulated breast tumor heterogeneity informing a looping-mediated therap...
I interferon signalling. RIG-I agonists and antagonists that enhance or prevent formation of disulfide-linked RIG-I oligomers, respectively, confirm that this mechanism is crucial for RIG-I function and could be harnessed to boost antiviral immunity or suppress autoimmunity caused by hyperactive RIG-...
我们的旗舰期刊《Cell》由 Benjamin Lewin 于 1974 年在麻省理工学院出版社的支持下创办。1986 年,Cell Press 成为一家独立出版商,随后创办了包括《Neuron》、《Immunity》和《Molecular Cell》在内的标志性期刊。我们于 1998 年加入了母公司爱思唯尔家族。
Cell Death and Disease is an online journal in the field of translational cell death. It seeks to promote diverse and integrated areas of Experimental and Internal Medicine with its specialties, including Cancer, Immunity and Neuroscience.
In 1986, Cell Press became established as an independent publisher and subsequently launched hallmark journals including Neuron, Immunity, and Molecular Cell. We joined the Elsevier family, our parent company, in 1998. Today at Cell Press, our editorial and production teams collaborate with authors ...
西湖大学谢琦课题组一直从事肿瘤的靶向和免疫治疗研究,取得了一系列的研究成果,研究成果以通讯作者(含共同)身份发表在Cell, Nature Biomedical Engineering, Cancer Discovery, Immunity等国际著名杂志上,详情见实验室主页:https://xieqi.lab.w...
高影响力期刊（如 Cell、Nature Cell Biology）：适合突破性研究，审稿周期长，竞争激烈。专业领域期刊（如 Neuron、Immunity）：适合聚焦特定方向的研究，审稿相对高效。开放获取期刊（如 Cell Reports、iScience）：审稿快，适合需要快速发表的研究。如何获取完整期刊列表？访问 Cell Press 官网（www.cell.com）或关注 ...